Page last updated: 2024-12-10

cannabigerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cannabigerol: RN given refers to (E)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cannabigerol : A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
HelichrysumgenusA plant genus of the family ASTERACEAE. Members contain CHALCONE, helichrysetin, arenarin, and flamin.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
CannabisgenusThe plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.[MeSH]CannabaceaeA plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.[MeSH]
Cannabis sativaspecies[no description available]CannabaceaeA plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.[MeSH]

Cross-References

ID SourceID
PubMed CID5315659
CHEMBL ID497318
CHEBI ID69477
SCHEMBL ID144819
SCHEMBL ID14764730
MeSH IDM0112336

Synonyms (41)

Synonym
CBG ,
cannabigerol
1,3-benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (e)-
CHEMBL497318 ,
chebi:69477 ,
bdbm50318487
2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol
C20219
j1k406072n ,
25654-31-3
unii-j1k406072n
2808-33-5
(e)-2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol
(e)-2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-resorcinol
2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-pentylbenzene-1,3-diol
resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (e)-
1,3-benzenediol, 2-((2e)-3,7-dimethyl-2,6-octadien-1-yl)-5-pentyl-
SCHEMBL144819
SCHEMBL14764730
2-[(2e)-3,7-dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol
AKOS024457386
1,3-benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-
resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-
2-[(2e)-3,7-dimethyl-2,6-octadienyl]-5-pentyl-1,3-benzenediol #
gtpl11094
2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-pentyl-benzene-1,3-diol
geranylolivetol
cannabigerol (cbg)
BCP23754
Q412122
FS-9666
DB14734
EX-A5335
DTXSID701014168
cannabigerol (cbg) 100 microg/ml in methanol
cannabigerol (cbg) 1000 microg/ml in methanol
cannabigerol (1.0 mg/ml in methanol)
cannabigerol (cbg) 250 microg/ml in acetonitrile
(E)-2-(3,7-DIMETHYLOCTA-2,6-DIEN-1-YL)-5-PENTYLBENZENE-1,3-DIOL ,
F70893
cannabigerol (cbg), 1mg/ml in ethanol

Research Excerpts

Overview

Cannabigerol is a main phytocannabinoid, which has attracted significant pharmacological interest due to its non-psychotropic nature. It interacts with specific targets involved in carcinogenesis.

ExcerptReferenceRelevance
"Cannabigerol (CBG) is a minor non-psychoactive cannabinoid present in "( In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Fernandez, JR; Fitzgerald, C; Perez, E; Rouzard, K; Savile, C; Tamura, M, 2022
)
2.44
"Cannabigerol is a main phytocannabinoid, which has attracted significant pharmacological interest due to its non-psychotropic nature."( Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo.
Alfahel, L; Amoyal, M; Ben-Shabat, S; Bernstein, N; Dahan, A; Feinshtein, V; Fleisher-Berkovich, S; Gorelick, J; Israelson, A; Ventura, Y, 2023
)
1.9
"Cannabigerol (CBG) is a safe non-psychotropic Cannabis-derived cannabinoid (CB), which interacts with specific targets involved in carcinogenesis. "( Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.
Borrelli, F; Buono, L; Coppola, D; De Petrocellis, L; Izzo, AA; Maiello, F; Orlando, P; Pagano, E; Panzera, S; Romano, B, 2014
)
2.09

Effects

ExcerptReferenceRelevance
"Cannabigerol (CBG) has only recently been reported to prevent the progression of certain carcinomas and has not yet been studied in glioblastoma."( Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma.
Bošnjak, R; Breznik, B; Lah, TT; Majc, B; Marinelli, O; Mlinar, M; Nabissi, M; Novak, M; Pena Almidon, MA; Zomer, R; Žvar Baškovič, B, 2021
)
2.79

Toxicity

ExcerptReferenceRelevance
" As cannabigerol lacked these toxicities, it appears that the ocular hypotensive effect of this cannabinoid is somewhat dissociable from both the adverse central and ocular effects accompanying marihuana intake."( Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.
Allara, RD; Colasanti, BK; Craig, CR, 1984
)
1.04
"There was one adverse event (AE) in the active group (diarrhea) and two AEs in placebo (dry mouth; eye rash/swollen eye)."( A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOM
Antonio, J; Bonn-Miller, MO; Eglit, GML; Harrison, A; Peters, EN; Turcotte, C; Yardley, H, 2023
)
1.11

Pharmacokinetics

ExcerptReferenceRelevance
"We here determined pharmacokinetic profiles of the above phytocannabinoids after acute single-dose intraperitoneal and oral administration in mice and rats."( Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi
Amada, N; Arthur, M; Close, S; Deiana, S; Dorward, P; Fleming, S; Pigliacampo, B; Platt, B; Riedel, G; Watanabe, A; Woodcock, H; Yamasaki, Y, 2012
)
0.59
" CBD inhibited obsessive-compulsive behaviour in a time-dependent manner matching its pharmacokinetic profile."( Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi
Amada, N; Arthur, M; Close, S; Deiana, S; Dorward, P; Fleming, S; Pigliacampo, B; Platt, B; Riedel, G; Watanabe, A; Woodcock, H; Yamasaki, Y, 2012
)
0.59
" The aim of this study was to investigate similar dosing of CBG and CBGA from hemp plants that have been used for cannabidiol pharmacokinetic studies."( Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation.
Amstutz, K; Ellis, K; Gomez, B; Lyubimov, A; Schwark, WS; Venator, KP; Wakshlag, JJ; Zakharov, A, 2022
)
0.98

Bioavailability

ExcerptReferenceRelevance
" However, the potential therapeutic use of cannabis and cannabinoids for the treatment of respiratory diseases has not been widely investigated, in part because of local irritation of airways by needing to smoke the cannabis, poor bioavailability when administered orally due to the lipophilic nature of cannabinoids, and the psychoactive effects of Δ9-Tetrahydrocannabinol (Δ9-THC) found in cannabis."( The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Clarkson, N; Horniman, N; Keir-Rudman, S; Page, C; Robaina Cabrera, CL, 2021
)
0.88
" However, due to their low water solubility and prominent first-pass metabolism, their oral bioavailability is moderate, which is unfavorable for medicinal use."( Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives.
Ádám, D; Bácskay, I; Bereczki, I; Borbás, A; Herczeg, M; Herczegh, P; Hodek, J; Lőrincz, EB; Minorics, R; Nagy, L; Oláh, A; Ostorházi, E; Spolárics, J; Tóth, G; Weber, J; Zouboulis, CC; Zupkó, I, 2023
)
1.16

Dosage Studied

ExcerptRelevanceReference
"6 mg Δ9-tetrahydrocannabinol (THC) in a randomized, placebo-controlled, within-subject dosing design."( Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Abulseoud, OA; Andersson, M; Barnes, AJ; Blount, BC; Huestis, MA; Newmeyer, MN; Schroeder, J; Sempio, C; Smith, ML, 2020
)
0.56
" The aim of this study was to investigate similar dosing of CBG and CBGA from hemp plants that have been used for cannabidiol pharmacokinetic studies."( Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation.
Amstutz, K; Ellis, K; Gomez, B; Lyubimov, A; Schwark, WS; Venator, KP; Wakshlag, JJ; Zakharov, A, 2022
)
0.98
" Overall, this study indicates that CBG is promising for developing a transdermal dosage for pain management."( The antinociceptive activity and mechanism of action of cannabigerol.
Li, R; Lin, G; Wang, Z; Wen, Y; Zhang, J; Zhang, R; Zhu, Y, 2023
)
1.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
appetite enhancerA drug which increases appetite.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
cannabinoid receptor agonistAn agonist that binds to and activates cannabinoid receptors.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
neuroprotective agentAny compound that can be used for the treatment of neurodegenerative disorders.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phytocannabinoidA class of cannabinoid which are C21 terpenophenolic compounds isolated primarily from Cannabis sativa.
resorcinolsAny benzenediol in which the two hydroxy groups are meta to one another.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)IC50 (µMol)13.00000.05102.47257.5000AID1845627
Inhibin alpha chainHomo sapiens (human)IC50 (µMol)5.20005.20005.20005.2000AID1845667
Cannabinoid receptor 1Rattus norvegicus (Norway rat)Ki0.44000.00020.566510.0000AID1845663
Cannabinoid receptor 1Homo sapiens (human)IC50 (µMol)3.31000.00010.275310.0000AID617994
Cannabinoid receptor 1Homo sapiens (human)Ki1.41900.00010.50779.6000AID1625146; AID1845664; AID617994
Cannabinoid receptor 2 Homo sapiens (human)IC50 (µMol)3.46000.00081.58409.8000AID617995
Cannabinoid receptor 2 Homo sapiens (human)Ki1.23830.00000.415610.0000AID1625147; AID1845661; AID1845662; AID617995
N-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)IC50 (µMol)100.00000.70000.70000.7000AID1625159
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)IC50 (µMol)13.00000.45003.42437.5000AID618004
Transient receptor potential cation channel subfamily M member 8Homo sapiens (human)IC50 (µMol)0.16000.02001.27553.9000AID1845631
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)IC50 (µMol)2.60000.00020.606010.0000AID1845614; AID617998
Transient receptor potential cation channel subfamily V member 3Homo sapiens (human)IC50 (µMol)66.00003.00006.20009.4000AID1845620
Transient receptor potential cation channel subfamily M member 8Rattus norvegicus (Norway rat)IC50 (µMol)0.16000.05802.65048.3000AID618005
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)IC50 (µMol)1.30000.01802.01349.9000AID1845623
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)IC50 (µMol)1.50000.03701.93458.6000AID618001
Diacylglycerol lipase-alphaHomo sapiens (human)IC50 (µMol)100.00000.00101.05385.0119AID1625150
Transient receptor potential cation channel subfamily V member 2Homo sapiens (human)IC50 (µMol)1.50000.80002.93336.5000AID1845617
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)0.70000.00033.166210.0000AID1845625
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)EC50 (µMol)15.70000.00000.992210.0000AID1657599
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)EC50 (µMol)2.05000.06002.22238.4000AID482146; AID618003
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)1.30000.00051.06746.3096AID1845612; AID617997
Transient receptor potential cation channel subfamily V member 3Homo sapiens (human)EC50 (µMol)1.00001.00002.74005.3000AID1845618
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)EC50 (µMol)5.10000.04902.60986.4000AID1845621
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)EC50 (µMol)1.70000.03000.45071.7000AID618000
Transient receptor potential cation channel subfamily V member 2Homo sapiens (human)EC50 (µMol)1.70001.70004.36677.3000AID1845615
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alpha-2A adrenergic receptorHomo sapiens (human)EC5 (µMol)0.00200.00200.00200.0020AID1845666
Cannabinoid receptor 1Homo sapiens (human)K1.04001.04001.04001.0400AID1845660
Cannabinoid receptor 1Mus musculus (house mouse)K0.38000.38000.38000.3800AID1845596
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (261)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
skeletal system developmentInhibin alpha chainHomo sapiens (human)
ovarian follicle developmentInhibin alpha chainHomo sapiens (human)
signal transductionInhibin alpha chainHomo sapiens (human)
cell surface receptor signaling pathwayInhibin alpha chainHomo sapiens (human)
cell-cell signalingInhibin alpha chainHomo sapiens (human)
male gonad developmentInhibin alpha chainHomo sapiens (human)
cell differentiationInhibin alpha chainHomo sapiens (human)
erythrocyte differentiationInhibin alpha chainHomo sapiens (human)
negative regulation of type II interferon productionInhibin alpha chainHomo sapiens (human)
regulation of cell population proliferationInhibin alpha chainHomo sapiens (human)
negative regulation of phosphorylationInhibin alpha chainHomo sapiens (human)
hemoglobin biosynthetic processInhibin alpha chainHomo sapiens (human)
negative regulation of B cell differentiationInhibin alpha chainHomo sapiens (human)
negative regulation of macrophage differentiationInhibin alpha chainHomo sapiens (human)
negative regulation of cell cycleInhibin alpha chainHomo sapiens (human)
positive regulation of follicle-stimulating hormone secretionInhibin alpha chainHomo sapiens (human)
negative regulation of follicle-stimulating hormone secretionInhibin alpha chainHomo sapiens (human)
regulation of cell cycleInhibin alpha chainHomo sapiens (human)
positive regulation of cytokine productionAlpha-2A adrenergic receptorHomo sapiens (human)
DNA replicationAlpha-2A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
Ras protein signal transductionAlpha-2A adrenergic receptorHomo sapiens (human)
Rho protein signal transductionAlpha-2A adrenergic receptorHomo sapiens (human)
female pregnancyAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of cell population proliferationAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2A adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-2A adrenergic receptorHomo sapiens (human)
actin cytoskeleton organizationAlpha-2A adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of cell migrationAlpha-2A adrenergic receptorHomo sapiens (human)
activation of protein kinase activityAlpha-2A adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2A adrenergic receptorHomo sapiens (human)
cellular response to hormone stimulusAlpha-2A adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2A adrenergic receptorHomo sapiens (human)
vasodilationAlpha-2A adrenergic receptorHomo sapiens (human)
glucose homeostasisAlpha-2A adrenergic receptorHomo sapiens (human)
fear responseAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of potassium ion transportAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of MAP kinase activityAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion-dependent exocytosisAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretionAlpha-2A adrenergic receptorHomo sapiens (human)
intestinal absorptionAlpha-2A adrenergic receptorHomo sapiens (human)
thermoceptionAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of lipid catabolic processAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of membrane protein ectodomain proteolysisAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion transportAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretion involved in cellular response to glucose stimulusAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of uterine smooth muscle contractionAlpha-2A adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-inhibiting adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
phospholipase C-activating adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of wound healingAlpha-2A adrenergic receptorHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion transmembrane transporter activityAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of acute inflammatory response to antigenic stimulusCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
spermatogenesisCannabinoid receptor 1Homo sapiens (human)
axonal fasciculationCannabinoid receptor 1Homo sapiens (human)
response to nutrientCannabinoid receptor 1Homo sapiens (human)
memoryCannabinoid receptor 1Homo sapiens (human)
positive regulation of neuron projection developmentCannabinoid receptor 1Homo sapiens (human)
negative regulation of serotonin secretionCannabinoid receptor 1Homo sapiens (human)
positive regulation of fever generationCannabinoid receptor 1Homo sapiens (human)
negative regulation of fatty acid beta-oxidationCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, GABAergicCannabinoid receptor 1Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 1Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 1Homo sapiens (human)
negative regulation of dopamine secretionCannabinoid receptor 1Homo sapiens (human)
response to nicotineCannabinoid receptor 1Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 1Homo sapiens (human)
response to cocaineCannabinoid receptor 1Homo sapiens (human)
glucose homeostasisCannabinoid receptor 1Homo sapiens (human)
positive regulation of apoptotic processCannabinoid receptor 1Homo sapiens (human)
response to ethanolCannabinoid receptor 1Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 1Homo sapiens (human)
negative regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
positive regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
regulation of insulin secretionCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicCannabinoid receptor 1Homo sapiens (human)
maternal process involved in female pregnancyCannabinoid receptor 1Homo sapiens (human)
regulation of feeding behaviorCannabinoid receptor 1Homo sapiens (human)
regulation of penile erectionCannabinoid receptor 1Homo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidCannabinoid receptor 1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationCannabinoid receptor 1Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 1Homo sapiens (human)
response to amphetamineCannabinoid receptor 2 Homo sapiens (human)
inflammatory responseCannabinoid receptor 2 Homo sapiens (human)
immune responseCannabinoid receptor 2 Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 2 Homo sapiens (human)
leukocyte chemotaxisCannabinoid receptor 2 Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicCannabinoid receptor 2 Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 2 Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 2 Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 2 Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 2 Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of cholesterol effluxPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
long-chain fatty acid transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of osteoblast differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of receptor signaling pathway via STATPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of low-density lipoprotein receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of MAP kinase activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adiponectin secretionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cardiac muscle hypertrophy in response to stressPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of connective tissue replacement involved in inflammatory response wound healingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
placenta developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
G protein-coupled receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of blood pressurePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of lipid storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of angiogenesisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
monocyte differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
epithelial cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to lipidPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
glucose homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
mRNA transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipoprotein transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of blood vessel endothelial cell migrationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
innate immune responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell fate commitmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
retinoic acid receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell maturationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
rhythmic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
white fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of SMAD protein signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cholesterol transporter activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to low-density lipoprotein particle stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of mitochondrial fissionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of extracellular matrix assemblyPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cellular response to transforming growth factor beta stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adipose tissue developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular associated smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular endothelial cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
fatty acid metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
sphingosine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lipid catabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylphosphatidylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
positive regulation of cold-induced thermogenesisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to temperature stimulusTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
negative regulation of hair cycleTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
positive regulation of calcium ion importTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to hypoxiaTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell volume homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell-cell junction assemblyTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensory signaling pathwayTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to mechanical stimulusTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage chemotaxisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of neuron projection developmentTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin cytoskeleton organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
vasopressin secretionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of microtubule depolymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of interleukin-6 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to insulinTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
hyperosmotic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
glucose homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of vascular permeabilityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical microtubule organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of striated muscle contractionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of JNK cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule polymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of inflammatory responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
multicellular organismal-level water homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cartilage development involved in endochondral bone morphogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion importTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of monocyte chemotactic protein-1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage inflammatory protein 1 alpha productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-C motif) ligand 5 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
blood vessel endothelial cell delaminationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import into cytosolTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of brown fat cell differentiationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of aerobic respirationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
monoacylglycerol biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayDiacylglycerol lipase-alphaHomo sapiens (human)
neuroblast proliferationDiacylglycerol lipase-alphaHomo sapiens (human)
arachidonic acid metabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
diacylglycerol catabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidDiacylglycerol lipase-alphaHomo sapiens (human)
regulation of neuroinflammatory responseDiacylglycerol lipase-alphaHomo sapiens (human)
cannabinoid biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
response to temperature stimulusTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
sensory perceptionTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of axon extensionTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of calcium ion importTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of cold-induced thermogenesisTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (83)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein bindingInhibin alpha chainHomo sapiens (human)
signaling receptor bindingInhibin alpha chainHomo sapiens (human)
cytokine activityInhibin alpha chainHomo sapiens (human)
hormone activityInhibin alpha chainHomo sapiens (human)
protein bindingInhibin alpha chainHomo sapiens (human)
growth factor activityInhibin alpha chainHomo sapiens (human)
inhibin bindingInhibin alpha chainHomo sapiens (human)
protein-containing complex bindingInhibin alpha chainHomo sapiens (human)
alpha2-adrenergic receptor activityAlpha-2A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2A adrenergic receptorHomo sapiens (human)
protein kinase bindingAlpha-2A adrenergic receptorHomo sapiens (human)
alpha-1B adrenergic receptor bindingAlpha-2A adrenergic receptorHomo sapiens (human)
alpha-2C adrenergic receptor bindingAlpha-2A adrenergic receptorHomo sapiens (human)
thioesterase bindingAlpha-2A adrenergic receptorHomo sapiens (human)
heterotrimeric G-protein bindingAlpha-2A adrenergic receptorHomo sapiens (human)
protein homodimerization activityAlpha-2A adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-2A adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2A adrenergic receptorHomo sapiens (human)
norepinephrine bindingAlpha-2A adrenergic receptorHomo sapiens (human)
guanyl-nucleotide exchange factor activityAlpha-2A adrenergic receptorHomo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 1Homo sapiens (human)
identical protein bindingCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 2 Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 2 Homo sapiens (human)
transcription cis-regulatory region bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
transcription coregulator bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
double-stranded DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
prostaglandin receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
enzyme bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peptide bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
identical protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear retinoid X receptor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
arachidonic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA binding domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
LBD domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
alpha-actinin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
R-SMAD bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
E-box bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
STAT family protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
hydrolase activity, acting on carbon-nitrogen (but not peptide) bondsN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylsphingosine amidohydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
fatty acid amide hydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-(long-chain-acyl)ethanolamine deacylase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
ceramidase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
DNA-binding transcription factor bindingN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
ligand-gated calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
actin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensor activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase C bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
monoatomic cation channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lipid bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
stretch-activated, monoatomic cation-selective, calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
SH2 domain bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
alpha-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
beta-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein bindingDiacylglycerol lipase-alphaHomo sapiens (human)
metal ion bindingDiacylglycerol lipase-alphaHomo sapiens (human)
acylglycerol lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
lipoprotein lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
monoatomic cation channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
monoatomic ion transmembrane transporter activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (59)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
photoreceptor outer segmentInhibin alpha chainHomo sapiens (human)
photoreceptor inner segmentInhibin alpha chainHomo sapiens (human)
extracellular regionInhibin alpha chainHomo sapiens (human)
neuronal cell bodyInhibin alpha chainHomo sapiens (human)
inhibin-betaglycan-ActRII complexInhibin alpha chainHomo sapiens (human)
inhibin A complexInhibin alpha chainHomo sapiens (human)
inhibin B complexInhibin alpha chainHomo sapiens (human)
extracellular spaceInhibin alpha chainHomo sapiens (human)
cytoplasmAlpha-2A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
basolateral plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
neuronal cell bodyAlpha-2A adrenergic receptorHomo sapiens (human)
axon terminusAlpha-2A adrenergic receptorHomo sapiens (human)
presynaptic active zone membraneAlpha-2A adrenergic receptorHomo sapiens (human)
dopaminergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
postsynaptic density membraneAlpha-2A adrenergic receptorHomo sapiens (human)
glutamatergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
GABA-ergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
receptor complexAlpha-2A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
mitochondrial outer membraneCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
actin cytoskeletonCannabinoid receptor 1Homo sapiens (human)
growth coneCannabinoid receptor 1Homo sapiens (human)
presynaptic membraneCannabinoid receptor 1Homo sapiens (human)
membrane raftCannabinoid receptor 1Homo sapiens (human)
glutamatergic synapseCannabinoid receptor 1Homo sapiens (human)
GABA-ergic synapseCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
cytoplasmCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
dendriteCannabinoid receptor 2 Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneCannabinoid receptor 2 Homo sapiens (human)
perikaryonCannabinoid receptor 2 Homo sapiens (human)
endoplasmic reticulumCannabinoid receptor 2 Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
cytoplasmCannabinoid receptor 2 Homo sapiens (human)
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cytosolPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
intracellular membrane-bounded organellePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II transcription regulator complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
receptor complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cytoplasmN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
membraneN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomal lumenN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
extracellular exosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
endoplasmic reticulum membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
membrane raftTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cytoplasmTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
lysosomeTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
receptor complexTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
cytoplasmic microtubuleTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
endoplasmic reticulumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
adherens junctionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
focal adhesionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell surfaceTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
apical plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lamellipodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
filopodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
growth coneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical actin cytoskeletonTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ruffle membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneDiacylglycerol lipase-alphaHomo sapiens (human)
early endosome membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendritic spine membraneDiacylglycerol lipase-alphaHomo sapiens (human)
varicosityDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic density membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
cytoplasmDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic membraneDiacylglycerol lipase-alphaHomo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
cell surfaceTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
growth cone membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
melanosomeTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
axonal growth coneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
cell bodyTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (65)

Assay IDTitleYearJournalArticle
AID362541Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1199B after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1625156Inhibition of FAAH in rat brain membranes using [14C]-AEA as substrate measured after 30 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625152Inhibition of recombinant human DAGLalpha expressed in COS7 cells at 100 uM using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625146Displacement of [3H]-CP55940 from recombinant human CB1 receptor expressed in Sf9 cell membranes co-expressing Galphai3beta1gamma2 measured after 90 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845596Agonist activity at CB1 receptor in albino MF1 mouse vas deferens assessed as inhibition of electrically evoked vas deferens contraction by incubated for 13 mins followed by electrical stimulation for 2 mins2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845618Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID617995Displacement of [3H]-CP-55,940 from human recombinant CB2 receptor expressed in HEK293 cells membrane incubated for 90 mins2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1133174Antihemolytic potency against hypotonic lysis-induced erythrocytes (unknown origin) assessed as stabilization1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids.
AID1625159Inhibition of recombinant human NAAA expressed in HEK293 cells using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845619Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1133175Molar volume, Vm of the compound at zero temperature1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids.
AID1625158Inhibition of FAAH in rat brain membranes at 100 uM using [14C]-AEA as substrate measured after 30 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845620Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) channel desensitization in presence of carvacrol2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845667Inhibition of Inh (unknown origin)2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID618005Antagonist activity at rat recombinant TRPM8 receptor expressed in HEK293 cells assessed as inhibition of 0.25 uM icilin-induced stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1845616Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845661Displacement of [3H]-WIN55212-2 from human CB2 receptor transfected in CHO cell membrane incubated for 90 mins by Liquid scintillation counter analysis2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845668Antibiofilm activity against methicillin-resistant Staphylococcus aureus USA300 incubated for 24 hrs by crystal violet staining based assay2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID617996Agonist activity at human TRPv1 receptor expressed in HEK293 cells assessed as stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay relative to 4 uM ionomycin2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1845666Displacement of [35S]GTPgammaS from human alpha2-adreno receptor receptor expressed in CHO cells2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1782665Inhibition of human LDHB assessed as reduction in lactate production using pyruvate as substrate at 10 uM in presence of NADH by spectrophotometric analysis relative to control2021Journal of natural products, 05-28, Volume: 84, Issue:5
Cannabichromene and Δ
AID1845631Antagonist activity at TRPM8 (unknown origin) ion channel2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845627Agonist activity at TRPA1 (unknown origin) channel desensitization in presence of isothiocyanate2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845622Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845612Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID362546Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1845623Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) channel desensitization in presence of 4alphaPDD2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID482146Agonist activity at rat TRPA1 channel expressed in HEK293 cells assessed as increase in intracellular calcium influx2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1657599Agonist activity at GAL4-tagged PPARgamma (unknown origin) transiently expressed in HEK293T cells co-transfected with GAL4-tagged luc incubated for 6 hrs by dual luciferase reporter gene assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
The Oxidation of Phytocannabinoids to Cannabinoquinoids.
AID362545Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1625147Displacement of [3H]-CP55940 from recombinant human CB2 receptor expressed in Sf9 cell membranes co-expressing Galphai3beta1gamma2 measured after 90 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845660Displacement of [3H]-WIN55212-2 from human CB1 receptor transfected in CHO cell membrane incubated for 90 mins by Liquid scintillation counter analysis2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845669Antibiofilm activity against methicillin-resistant Staphylococcus aureus USA300 incubated for 24 hrs by CLSI based assay2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID362543Antibacterial activity against tetracycline-resistant Staphylococcus aureus XU212 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID1845626Agonist activity at TRPA1 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1133173Inhibition of mouse brain synaptosomal Lysophosphatidylcholine acyltransferase using substrate [32P]lysophosphatidylcholine and oleoyl-CoA1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids.
AID1845671Antimycobacterial activity against Escherichia coli in presence of polymyxin2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID618002Agonist activity at rat recombinant TRPA1 receptor expressed in HEK293 cells assessed as stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay relative to allyl isothiocyanate2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1845625Agonist activity at TRPA1 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID618004Antagonist activity at rat recombinant TRPA1 receptor expressed in HEK293 cells assessed as inhibition of 100 uM allyl isothiocyanate-induced stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID617997Agonist activity at human TRPv1 receptor expressed in HEK293 cells assessed as stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1625162Inhibition of [14C]-AEA uptake in rat RBL2H3 cells by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID617994Displacement of [3H]-CP-55,940 from human recombinant CB1 receptor expressed in HEK293 cells membrane incubated for 90 mins2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1845665Agonist activity at CB2 receptor in albino MF1 mouse vas deferens assessed as inhibition of electrically evoked vas deferens contraction by incubated for 13 mins followed by electrical stimulation for 2 mins2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID362542Antibacterial activity against macrolide-resistant Staphylococcus aureus RN4220 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID618000Agonist activity at rat recombinant TRPV2 receptor expressed in HEK293 cells assessed as stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1625154Inhibition of MAGL in African green monkey COS cell homogenates at 100 uM using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845617Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) channel desensitization in presence of lysophosphatidylcholine2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625163Inhibition of [14C]-AEA uptake in rat RBL2H3 cells at 25 uM by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845614Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) channel desensitization in presence of capsaicin2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID618003Agonist activity at rat recombinant TRPA1 receptor expressed in HEK293 cells assessed as stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID362544Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID618001Antagonist activity at rat recombinant TRPV2 receptor expressed in HEK293 cells assessed as inhibition of 3 uM lysophosphatidylcholine-induced stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1845621Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625153Inhibition of MAGL in African green monkey COS cell homogenates using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845670Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in mouse assessed as log10 reduction in bacterial load in spleen at 100 mg/kgip measured for 30 mins2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID617999Agonist activity at rat recombinant TRPV2 receptor expressed in HEK293 cells assessed as stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay relative to 4 uM ionomycin2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1845664Displacement of [35S]GTPgammaS from human CB1 receptor expressed in CHO cells2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID617998Antagonist activity at human TRPv1 receptor expressed in HEK293 cells assessed as inhibition of 0.1 um capsaicin-induced stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).
AID1625150Inhibition of recombinant human DAGLalpha expressed in COS7 cells using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845615Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845613Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845663Displacement of [35S]GTPgammaS from CB1 receptor in rat brain2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625161Inhibition of recombinant human NAAA expressed in HEK293 cells at 50 uM using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845662Displacement of [3H]-CP55940 from CB2 receptor (unknown origin) expressed in CHO cells2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (3.88)18.7374
1990's3 (2.91)18.2507
2000's4 (3.88)29.6817
2010's41 (39.81)24.3611
2020's51 (49.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.71 (24.57)
Research Supply Index4.67 (2.92)
Research Growth Index5.67 (4.65)
Search Engine Demand Index83.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (2.91%)5.53%
Reviews5 (4.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.97%)0.25%
Other94 (91.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]